Susquehanna International Group
TMCI icon

Susquehanna International Group’s Treace Medical Concepts TMCI Stock Holding History

Susquehanna International Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,900
Closed -$117K – 14115
2025
Q4 		$117K Buy
+47,900
New +$208K ﹤0.01% 11361
2024
Q4 		– Sell
-127,400
Closed -$739K – 13222
2024
Q3 		$739K Sell
127,400
-7,600
-6% -$48.8K ﹤0.01% 7528
2024
Q2 		$898K Buy
135,000
+112,000
+487% +$905K ﹤0.01% 6848
2024
Q1 		$300K Sell
23,000
-9,300
-29% -$124K ﹤0.01% 9688
2023
Q4 		$412K Buy
32,300
+6,800
+27% +$68.7K ﹤0.01% 9118
2023
Q3 		$334K Buy
+25,500
New +$467K ﹤0.01% 9121
2023
Q2 		– Sell
-18,700
Closed -$471K – 13138
2023
Q1 		$471K Buy
+18,700
New +$439K ﹤0.01% 8705
2022
Q2 		– Sell
-12,700
Closed -$240K – 13941
2022
Q1 		$240K Buy
12,700
+400
+3% +$7.78K ﹤0.01% 10804
2021
Q4 		$229K Buy
+12,300
New +$254K ﹤0.01% 11156

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Susquehanna International Group's TMCI Position: Q2 2026 in Review

Susquehanna International Group increased its Treace Medical Concepts (TMCI) stake by 1,156% in Q2 2026, buying an estimated $542K and bringing the position to 214,219 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #8605.

Susquehanna International Group first reported a position in TMCI in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.13M in Q1 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Susquehanna International Group held 214,219 shares of Treace Medical Concepts worth $853K as of Q2 2026.
  • Susquehanna International Group bought 197,170 Treace Medical Concepts shares in Q2 2026, an estimated $542K.
  • Treace Medical Concepts made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #8605 holding.
  • Susquehanna International Group first reported a position in Treace Medical Concepts in Q2 2022 and has held it in 15 quarters since.
  • Susquehanna International Group's Treace Medical Concepts position peaked at $1.13M in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.